Published: 06/13/2022 11:46 GMT Ionis Pharmaceuticals Inc (IONS) - Ionis Treatment for Angelman Syndrome Receives Orphan Drug and Rare Pediatric Disease Designations From U.S. FDA.
Ionis Treatment for Angelman Syndrome Receives Orphan Drug and Rare Pediatric Disease Designations From U.S. FDA.